Paul Burton - 05 Aug 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Medical Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
05 Aug 2021
Net transactions value
$0
Form type
4
Filing time
09 Aug 2021, 16:29:45 UTC
Previous filing
06 Jul 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MRNA Stock Option (Right to Buy) 15,002 05 Aug 2021 Common Stock 15,002 $416.26 Direct F1
holding MRNA Restricted Stock Units 6,438 05 Aug 2021 Common Stock 6,438 $0.000000 Direct F2
holding MRNA Restricted Stock Units 3,219 05 Aug 2021 Common Stock 3,219 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option will vest and become exercisable on August 5, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to this restricted stock unit award will vest on August 5, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 The shares subject to this restricted stock unit award will vest in full on August 5, 2024, subject to the recipient's continued service.